Results 31 to 40 of about 38,676 (197)

A novel lineage-tracing mouse model for studying early MmuPV1 infections

open access: yeseLife, 2022
Human papillomaviruses are DNA viruses that ubiquitously infect humans and have been associated with hyperproliferative lesions. The recently discovered mouse specific papillomavirus (MmuPV1) provides the opportunity to study papillomavirus infections in
Vural Yilmaz   +4 more
doaj   +1 more source

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles [PDF]

open access: yesProceedings of the National Academy of Sciences, 1999
The vertebrate immune system has evolved to respond vigorously to microbial infection but to ignore self-antigens. Evidence has emerged that B cell responses to viruses are initiated by immune recognition of ordered arrays of antigen on the viral surface.
B, Chackerian, D R, Lowy, J T, Schiller
openaire   +2 more sources

Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.

open access: yesPLoS ONE, 2021
Anal squamous cell carcinoma (SCC) will be diagnosed in an estimated 9,080 adults in the United States this year, and rates have been rising over the last several decades.
Morgan T Walcheck   +7 more
doaj   +2 more sources

An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer

open access: yesmBio, 2020
Human papillomavirus (HPV) is the most common sexually transmitted pathogen, and high-risk HPVs contribute to 5% of human cancers, including 25% of head and neck squamous cell carcinomas (HNSCCs).
Tao Wei   +3 more
doaj   +1 more source

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]

open access: yesPLoS ONE, 2015
Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel   +5 more
doaj   +1 more source

Isolation of three novel rat and mouse papillomaviruses and their genomic characterization. [PDF]

open access: yes, 2012
Despite a growing knowledge about the biological diversity of papillomaviruses (PV), only little is known about non-human PV in general and about PV mice models in particular.
Ingo Nindl (126623)   +23 more
core   +1 more source

CD28-deficient mice are vulnerable to mouse papillomavirus MmuPV1 infection of the skin and mucosae. [PDF]

open access: yesPLoS Pathog
CD28 is a co-stimulatory molecule expressed on the surface of T cells. To date, three individuals with germline CD28 deficiency have been reported to develop recalcitrant, HPV-driven warts: one exhibited persistent lesions, another experienced disease resolution, and the third developed a chronic “tree-man” phenotype.
Brendle S   +15 more
europepmc   +2 more sources

MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.

open access: yesPLoS Pathogens, 2023
Human papillomaviruses (HPVs) contribute to approximately 5% of all human cancers. Species-specific barriers limit the ability to study HPV pathogenesis in animal models.
James C Romero-Masters   +12 more
doaj   +3 more sources

Papillomavirus E5: the smallest oncoprotein with many functions [PDF]

open access: yes, 2011
Papillomaviruses (PVs) are established agents of human and animal cancers. They infect cutaneous and mucous epithelia. High Risk (HR) Human PVs (HPVs) are consistently associated with cancer of the uterine cervix, but are also involved in the ...
Roperto, S.   +27 more
core   +1 more source

Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice. [PDF]

open access: yesPLoS ONE, 2016
Epidemiological evidence supports that infection with high-risk types of human papillomavirus (HPV) can interact with host and environmental risk factors to contribute to the development of cervical, oropharyngeal, and other anogenital cancers.
Lan He   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy